AHRQ Patient Safety Network

Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs.

Ranchon F, Salles G, Späth HM, et al. BMC Cancer. 2011;11:478.

This observational study, conducted at a French hospital, found that most chemotherapy medication errors resulted in near misses and did not cause harm to patients.

PubMed citation

Available at

Related Resources

STUDY

Chemotherapy safety and severe adverse events in cancer patients: strategies to efficiently avoid chemotherapy errors in in- and outpatient treatment.

Markert A, Thierry V, Kleber M, Behrens M, Engelhardt M. Int J Cancer. 2009;124:722-728.

STUDY

Predictors of prescription errors involving anticancer chemotherapy agents.

Ranchon F, Moch C, You B, et al. Eur J Cancer. 2012;48:1192-1199.

STUDY

Undiagnosed breast cancer at MR imaging: analysis of causes.

Pages EB, Millet I, Hoa D, Doyon FC, Taourel P. Radiology. 2012;264:40-50.

STUDY

Chemotherapy medication errors in a pediatric cancer treatment center: prospective characterization of error types and frequency and development of a quality improvement initiative to lower the error rate.

Watts RG, Parsons K. Pediatr Blood Cancer. 2013 Mar 20; [Epub ahead of print].

View all related resources...

Download: Adobe Reader email icon

Find Related Resources by...

Resource Type

Study

Setting of Care

Hospitals

Target Audience

Health Care Providers

Health Care Executives and Administrators

Clinical Area

Medical Oncology

Safety Target

Chemotherapeutic Agents

Error Types

Epidemiology of Errors and Adverse Events

Near Miss

Approach to Improving Safety

Error Analysis

Origin/Sponsor

Europe